Jammu to pioneer India’s first Cannabis Medicine Project

The ‘Cannabis Research Project’ of CSIR-IIIM Jammu, spearheaded by Prime Minister Narendra Modi, marks the first-ever initiative of its kind in India. This groundbreaking project is carried out in partnership with a Canadian firm ‘IndusScan’ with the aim of harnessing the potential of cannabis, a substance known for its abuse potential, for the benefit of humanity, particularly for patients afflicted with neuropathies, cancer, and epilepsy.

The Historic Collaboration Between CSIR-IIIM and IndusScan

The historic scientific agreement signed between CSIR-IIIM and IndusScan holds immense significance not only for J&K but also for the entire nation. It has the potential to revolutionize medicine production, ensuring that the country can produce and export medicines that were previously sourced from foreign countries.

This project will play a significant role in raising awareness about the diverse medicinal applications of this once-abused substance, particularly in providing relief to patients suffering from malignancies and various other diseases.

From the perspective of Atma-Nirbhar Bharat (self-reliant India), once all the necessary approvals are obtained, this initiative will enable the production of high-quality drugs suitable for treating different types of neuropathies, diabetic pains, and more, fostering self-sufficiency in the pharmaceutical sector.

CSIR-IIIM: Pioneering Scientific Research in India

CSIR-IIIM, the oldest scientific research institute in India, boasts a rich history of groundbreaking discoveries, including the identification of mint in the 1960s and its pivotal role in the purple revolution. Now, with the advent of the Cannabis Research Project, CSIR-IIIM is poised to elevate its status even further, cementing its position as a prestigious hub for scientific research in India.

Advancements in Medical Cannabis

Cannabis, a remarkable plant, has led to the approval of several drugs by the FDA, including Marilnol/nabilone and Cesamet, prescribed for managing nausea and vomiting. Sativex is another FDA-approved drug that utilizes cannabis for treating neuropathic pain and spasticity, while Epidiolex, containing Cannabidiol, has shown promising results in treating epilepsy. Furthermore, cannabis is being utilized for various medical purposes in other countries as well.

Key takeaways for competitive examinations

  • Chief Scientist at CSIR-IIIM Jammu: Dr Zabeer Ahmed

Find More Miscellaneous News Here

saurabh

Recent Posts

Which is the Largest Valley in Asia? Check Here

Valleys are low areas of land that lie between hills or mountains. They are formed…

11 hours ago

Which Place is known as the Sandwich Capital of the World?

Sandwiches are one of the most popular foods in the world. They are simple, quick…

14 hours ago

Centre Appoints Rohit Jain as Deputy Governor of Reserve Bank of India

The Government of India has appointed Rohit Jain as the Deputy Governor of the Reserve…

15 hours ago

Government Notifies New Citizenship Rules, Streamlines OCI and Application Processes

The Government of India has notified the Citizenship (Amendment) Rules, 2026 and introduced the important…

15 hours ago

Reserve Bank of India Says 98.47% of ₹2,000 Notes Returned to Banking System

The Reserve Bank of India have announced that 98.47% of ₹2,000 Indian currency notes have…

16 hours ago

Which Indian City is known as the Samosa Capital of India?

India is famous for its tasty food and snacks. Every city has its own special…

16 hours ago